Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pocard

Showing results (221-230 of 277) with videos related to

Pageof 28
Sort By:
Annals of Surgical Oncology|January 7, 2026
ASO Visual Abstract: Appendiceal Adenocarcinoma Discovered during Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC, a French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
Bulletin Du Cancer|January 23, 2015
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancerJeanne Netter, Jacqueline Lehmann-Che, Jerome Lambert, et al.
Annals of Surgical Oncology|January 16, 2026
ASO Authors Reflections: Prophylactic CRS and HIPEC, A Potential Therapeutic Option to Reduce Peritoneal Spreading Risk for Perforated Appendiceal Adenocarcinoma: A French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
Oncogene|October 17, 2003
Functional and molecular characterization of the epithelioid to round transition in human colorectal cancer LoVo cellsPhilip R Debruyne, Stefan J Vermeulen, Geert Berx, et al.
Annals of Surgical Oncology|February 28, 2016
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive FactorsThibaut Charrier, Guillaume Passot, Julien Peron, et al.
Annals of Surgical Oncology|November 25, 2025
Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC-A French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
Annals of Surgical Oncology|December 14, 2025
Correction: Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC-A French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
Pleura and Peritoneum|December 25, 2023
Second annual report from the ISSPP PIPAC databaseMichael Bau Mortensen, Francesco Casella, Özgül Düzgün, et al.
Annals of Surgical Oncology|July 7, 2018
Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE StudyBrice Malgras, Etienne Gayat, Olivier Aoun, et al.
The British Journal of Surgery|July 3, 2023
Developing a core set of patient-reported outcomes and patient-reported experience measures for peritoneal surface malignancies (COMETE)Abdelkader Taibi, Olivia Sgarbura, Laurent Villeneuve, et al.
Pageof 28

Showing results (221-230 of 277) with videos related to

Sort By:
Pageof 28
Annals of Surgical Oncology|January 7, 2026
ASO Visual Abstract: Appendiceal Adenocarcinoma Discovered during Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC, a French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
Bulletin Du Cancer|January 23, 2015
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancerJeanne Netter, Jacqueline Lehmann-Che, Jerome Lambert, et al.
Annals of Surgical Oncology|January 16, 2026
ASO Authors Reflections: Prophylactic CRS and HIPEC, A Potential Therapeutic Option to Reduce Peritoneal Spreading Risk for Perforated Appendiceal Adenocarcinoma: A French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
Oncogene|October 17, 2003
Functional and molecular characterization of the epithelioid to round transition in human colorectal cancer LoVo cellsPhilip R Debruyne, Stefan J Vermeulen, Geert Berx, et al.
Annals of Surgical Oncology|February 28, 2016
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive FactorsThibaut Charrier, Guillaume Passot, Julien Peron, et al.
Annals of Surgical Oncology|November 25, 2025
Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC-A French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
Annals of Surgical Oncology|December 14, 2025
Correction: Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC-A French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
Pleura and Peritoneum|December 25, 2023
Second annual report from the ISSPP PIPAC databaseMichael Bau Mortensen, Francesco Casella, Özgül Düzgün, et al.
Annals of Surgical Oncology|July 7, 2018
Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE StudyBrice Malgras, Etienne Gayat, Olivier Aoun, et al.
The British Journal of Surgery|July 3, 2023
Developing a core set of patient-reported outcomes and patient-reported experience measures for peritoneal surface malignancies (COMETE)Abdelkader Taibi, Olivia Sgarbura, Laurent Villeneuve, et al.
Pageof 28